Subsequent studies have led to the suggestion that the preinvasive phase may be shortened or even absent in hereditary breast cancers, particularly those associated with BRCA1 mutations (Jacquemler, Eisinger, Guinebretiere, Stoppa‐Lyonnet, & Sobol, 1996). The gene discussed is BRCA1; the disease is breast carcinoma.